It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...
Much to the Democrats’ chagrin, Robert F. Kennedy Jr. is now the United States’ new Health and Human Services secretary.
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
The Trump administration's decision to pause enforcement of an anti-bribery law raised the specter that drugmakers could ...
The Drug Testing Laboratory (DTL) has declared medicines of seven pharmaceutical companies as fake, claiming that some of the ...
Persistently high rates of both type 1 and 2 diabetes as well as racial health disparities are indicators of lingering gaps in care for Indigenous communities.